Literature DB >> 23702010

Impact of post-implant SAPIEN XT geometry and position on conduction disturbances, hemodynamic performance, and paravalvular regurgitation.

Ronald K Binder1, John G Webb, Stefan Toggweiler, Melanie Freeman, Marco Barbanti, Alexander B Willson, Donya Alhassan, Cameron J Hague, David A Wood, Jonathon Leipsic.   

Abstract

OBJECTIVES: This report sought to study the impact of the balloon-expandable SAPIEN XT (Edwards Lifesciences, Irvine, California) transcatheter heart valve (THV) stent frame geometry and position on outcomes of transcatheter aortic valve replacement (TAVR).
BACKGROUND: Post-implant THV geometry and position might impact atrioventricular conduction, hemodynamic performance, and annular sealing.
METHODS: Eighty-nine consecutive patients who underwent TAVR with a Sapien XT THV had pre- and post-implant multidetector computed tomography, transthoracic echocardiography, and electrocardiograms performed to assess THV stent geometry, atrioventricular conduction, and hemodynamic performance.
RESULTS: The THV Circularity (THV eccentricity <10% [eccentricity = minimum stent diameter/maximum stent diameter]) and under-expansion (THV area/nominal THV area <90%) were present in 97.8% (2 of 89) and 0%, respectively. Low THV implantation was associated with new left bundle branch block and complete heart block (3.4 ± 2.0 mm vs. 5.5 ± 2.9 mm, p = 0.01) and with the need for permanent pacemaker implantation (3.5 ± 2.0 mm vs. 7.1 ± 2.5 mm, p = 0.001). In contrast, labeled THV size and THV area oversizing was not associated with atrioventricular conduction disturbances. The relation between inflow stent frame area and annular area was related to paravalvular regurgitation (p = 0.025). Labeled prosthesis size but not prosthesis expansion or eccentricity was related to valve gradient (p = 0.005) and effective orifice area (p < 0.001).
CONCLUSIONS: Low implantation depth of balloon-expandable THVs is associated with clinically significant new conduction disturbances and permanent pacemaker implantation. Importantly, annular area oversizing was not associated with these complications.
Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23702010     DOI: 10.1016/j.jcin.2012.12.128

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  19 in total

Review 1.  Clinical significance of conduction disturbances after aortic valve intervention: current evidence.

Authors:  Manuel Martinez-Selles; Peter Bramlage; Martin Thoenes; Gerhard Schymik
Journal:  Clin Res Cardiol       Date:  2014-07-04       Impact factor: 5.460

2.  Permanent Pacemaker Implantation after TAVR - Predictors and Impact on Outcomes.

Authors:  Marcel Weber; Jan-Malte Sinning; Christoph Hammerstingl; Nikos Werner; Eberhard Grube; Georg Nickenig
Journal:  Interv Cardiol       Date:  2015-05

3.  Predictors of right ventricular pacing and pacemaker dependence in transcatheter aortic valve replacement patients.

Authors:  Esseim Sharma; Antony F Chu
Journal:  J Interv Card Electrophysiol       Date:  2017-12-19       Impact factor: 1.900

4.  Gated thoracic magnetic resonance angiography at 3T: noncontrast versus blood pool contrast.

Authors:  Chengcheng Zhu; Henrik Haraldsson; Kimberly Kallianos; Liang Ge; Elaine Tseng; Travis Henry; David Saloner; Michael D Hope
Journal:  Int J Cardiovasc Imaging       Date:  2017-09-13       Impact factor: 2.357

5.  Association of CKD with Outcomes Among Patients Undergoing Transcatheter Aortic Valve Implantation.

Authors:  Florian Lüders; Klaus Kaier; Gerrit Kaleschke; Katrin Gebauer; Matthias Meyborg; Nasser M Malyar; Eva Freisinger; Helmut Baumgartner; Holger Reinecke; Jochen Reinöhl
Journal:  Clin J Am Soc Nephrol       Date:  2017-03-13       Impact factor: 8.237

6.  Blood flow characteristics in the ascending aorta after TAVI compared to surgical aortic valve replacement.

Authors:  Ralf Felix Trauzeddel; Ulrike Löbe; Alex J Barker; Carmen Gelsinger; Christian Butter; Michael Markl; Jeanette Schulz-Menger; Florian von Knobelsdorff-Brenkenhoff
Journal:  Int J Cardiovasc Imaging       Date:  2015-10-22       Impact factor: 2.357

7.  Comparison between the SAPIEN S3 and the SAPIEN XT transcatheter heart valves: A single-center experience.

Authors:  Fadi J Sawaya; Marco Spaziano; Thierry Lefèvre; Andrew Roy; Phillippe Garot; Thomas Hovasse; Antoinette Neylon; Hakim Benamer; Mauro Romano; Thierry Unterseeh; Marie-Claude Morice; Bernard Chevalier
Journal:  World J Cardiol       Date:  2016-12-26

8.  Risk factors for paravalvular leak after transcatheter aortic valve implantation.

Authors:  Krzysztof Wilczek; Kamil Bujak; Rafał Reguła; Piotr Chodór; Tadeusz Osadnik
Journal:  Kardiochir Torakochirurgia Pol       Date:  2015-06-30

9.  The effect of X-ray beam distortion on the Edwards Sapien XT(™) trans-catheter aortic valve replacement prosthesis.

Authors:  James A Crowhurst; Karl K Poon; Dale Murdoch; Alexander Incani; Owen C Raffel; Annelise Liddicoat; Darren Walters
Journal:  J Med Radiat Sci       Date:  2015-08-30

Review 10.  Conduction disturbances after transcatheter aortic valve implantation procedures - predictors and management.

Authors:  Krzysztof Wilczek; Rafał Reguła; Kamil Bujak; Piotr Chodór; Michał Długaszek; Mariusz Gąsior
Journal:  Postepy Kardiol Interwencyjnej       Date:  2016-08-19       Impact factor: 1.426

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.